Bojun Chen

111 Dade Rd
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Shengmai Injection as adjunctive therapy in sepsis and septic shock: a retrospective cohort study.

Shengmai Injection as adjunctive therapy in sepsis and septic shock: a retrospective cohort study.

Journal: Frontiers in cellular and infection microbiology

Published: April 30, 2026

Corrigendum to "Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis" [J. Ethnopharmacol. (2025) 121096].

Corrigendum to "Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis" [J. Ethnopharmacol. (2025) 121096].

Journal: Journal of ethnopharmacology

Published: April 19, 2026

Naoxintong capsule as adjunctive therapy in ACS: a hypothesis-generating open-label randomized trial.

Naoxintong capsule as adjunctive therapy in ACS: a hypothesis-generating open-label randomized trial.

Journal: Frontiers in pharmacology

Published: April 05, 2026

Efficacy and safety of guanxinshutong capsule as adjunctive therapy for unstable angina: an integrated systematic review, meta-analysis, and network pharmacology study.

Efficacy and safety of guanxinshutong capsule as adjunctive therapy for unstable angina: an integrated systematic review, meta-analysis, and network pharmacology study.

Journal: Frontiers in cardiovascular medicine

Published: November 12, 2025

Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis.

Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis.

Journal: Journal of ethnopharmacology

Published: October 26, 2025

Modified Dachengqi Decoction ameliorates sepsis-induced lung injury via the gut microbiota-bile acid axis.

Modified Dachengqi Decoction ameliorates sepsis-induced lung injury via the gut microbiota-bile acid axis.

Journal: Frontiers in cellular and infection microbiology

Published: July 08, 2025

Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta-Analysis.

Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta-Analysis.

Journal: CNS neuroscience & therapeutics

Published: August 29, 2024

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway.

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway.

Journal: Frontiers in pharmacology

Published: June 14, 2024

Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.

Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: June 05, 2024

Effect of Fu Zheng Jie Du Formula on outcomes in patients with severe pneumonia receiving prone ventilation: a retrospective cohort study.

Effect of Fu Zheng Jie Du Formula on outcomes in patients with severe pneumonia receiving prone ventilation: a retrospective cohort study.

Journal: Frontiers in pharmacology

Published: May 07, 2024

IFI-16 inhibition attenuates myocardial remodeling following myocardial infarction.

IFI-16 inhibition attenuates myocardial remodeling following myocardial infarction.

Journal: iScience

Published: February 26, 2024

Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.

Efficacy and safety of Lianhua Qingwen granule in the treatment of non-influenza viral pneumonia: a randomized, double-blind, placebo-controlled, multicenter clinical study.

Journal: Frontiers in medicine

Published: September 26, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026